BALCHEM ($BCPC) is expected to release its quarterly earnings data on Tuesday, October 21st before market open, per Finnhub. Analysts are expecting revenue of $263,447,303 and earnings of $1.34 per share.
You can see Quiver Quantitative's $BCPC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BALCHEM Hedge Fund Activity
We have seen 206 institutional investors add shares of BALCHEM stock to their portfolio, and 157 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- APG ASSET MANAGEMENT N.V. removed 917,284 shares (-79.4%) from their portfolio in Q2 2025, for an estimated $146,031,612
- ASSENAGON ASSET MANAGEMENT S.A. added 191,621 shares (+221.3%) to their portfolio in Q3 2025, for an estimated $28,754,647
- BLACKROCK, INC. removed 112,431 shares (-2.2%) from their portfolio in Q2 2025, for an estimated $17,899,015
- WASATCH ADVISORS LP removed 108,916 shares (-10.2%) from their portfolio in Q2 2025, for an estimated $17,339,427
- PITCAIRN CO added 102,013 shares (+3083.8%) to their portfolio in Q2 2025, for an estimated $16,240,469
- GOLDMAN SACHS GROUP INC removed 97,749 shares (-39.6%) from their portfolio in Q2 2025, for an estimated $15,561,640
- TWO SIGMA INVESTMENTS, LP added 97,448 shares (+158.4%) to their portfolio in Q2 2025, for an estimated $15,513,721
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BALCHEM Analyst Ratings
Wall Street analysts have issued reports on $BCPC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 04/28/2025
To track analyst ratings and price targets for BALCHEM, check out Quiver Quantitative's $BCPC forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
